Catalys Pacific

Latest statistics and disclosures from Catalys Pacific's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Catalys Pacific consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Catalys Pacific

Catalys Pacific holds 3 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Mineralys Therapeutics (MLYS) 81.2 $108M 9.2M 11.70
 View chart
Hillevax (HLVX) 13.2 $18M 1.2M 14.46
 View chart
Phathom Pharmaceuticals (PHAT) 5.6 $7.4M 722k 10.30
 View chart

Past Filings by Catalys Pacific

SEC 13F filings are viewable for Catalys Pacific going back to 2024